BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7990348)

  • 1. [Sneddon's syndrome and Willebrand's factor antigen].
    Kalashnikova LA; Nasonov EL; Baranov AA; Aleksandrova EN
    Klin Med (Mosk); 1994; 72(3):29-32. PubMed ID: 7990348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sneddon's syndrome and antiphospholipid antibodies].
    Pérez Sempere A; Martínez Menéndez B; Bermejo F
    Neurologia; 1992 Nov; 7(9):280-1. PubMed ID: 1445719
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sneddon's syndrome and the primary antiphospholipid syndrome].
    Kalashnikova LA; Nasonov EL; Stoianovich LZ; Kovalev VIu; Kosheleva NM; Reshetniak TM
    Ter Arkh; 1993; 65(3):64-70. PubMed ID: 8059389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family.
    Lousa M; Sastre JL; Cancelas JA; Gobernado JM; Pardo A
    Stroke; 1994 May; 25(5):1071-4. PubMed ID: 8165682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in systemic lupus erythematosus and Sneddon's syndrome.
    Söhngen D; Wehmeier A; Specker C; Schneider W
    Semin Thromb Hemost; 1994; 20(1):55-63. PubMed ID: 8059234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelial antibodies in Sneddon's syndrome].
    Kalashnikova LA; Salozhin KV; Nasonov EL; Kosheleva NM; Reshetniak TM; Stoianovich LZ
    Ter Arkh; 1996; 68(1):54-6. PubMed ID: 8644034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.
    Sinisi L; Palma V; Di Girolamo C; Scarpa R; Faccenda F; Rubba P; Cirillo S; Mansi D
    Acta Neurol (Napoli); 1992 Apr; 14(2):134-9. PubMed ID: 1414558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers.
    Pettee AD; Wasserman BA; Adams NL; McMullen W; Smith HR; Woods SL; Ratnoff OD
    Neurology; 1994 Mar; 44(3 Pt 1):399-405. PubMed ID: 8145905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of Willebrand's factor antigen in patients with primary Sjogren's syndrome].
    Shilkina NP; Baranov AA; Varshavskaia AA; Makarushin AA; Nasonov EL; Panchenko KI; Nikolaev AG
    Ter Arkh; 1997; 69(12):15-8. PubMed ID: 9503526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Sneddon's syndrome.
    Mascarenhas R; Santo G; Gonçalo M; Ferro MA; Tellechea O; Figueiredo A
    Eur J Dermatol; 2003; 13(3):283-7. PubMed ID: 12804991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedo reticularis and cerebrovascular accidents (Sneddon's syndrome) as a clinical expression of antiphospholipid syndrome.
    Gantcheva M; Tsankov N
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):157-60. PubMed ID: 10343946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
    Mojzes J; Battyáni Z; Grexa E
    Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-beta 2 glycoprotein 1 antibodies in idiopathic livedo reticularis].
    Aubry F; Crickx B; Nicaise P; Labarre C; Viard JP; Belaïch S
    Ann Dermatol Venereol; 1995; 122(10):667-70. PubMed ID: 8687049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sneddon's syndrome associated with anticardiolipin antibody: a case report.
    Mutluer N; Yiğit A; Aydin N
    Acta Neurol Belg; 1992; 92(4):234-8. PubMed ID: 1441902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
    Szegedi N; May Z; Ováry C; Skopál J; Nagy Z
    Ideggyogy Sz; 2002 Mar; 55(3-4):102-8. PubMed ID: 12122979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sneddon's syndrome: generalized livedo reticularis and cerebrovascular disease. Importance of hemostatic screening.
    Devos J; Bulcke J; Degreef H; Michielsen B
    Dermatology; 1992; 185(4):296-9. PubMed ID: 1477426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sneddon's syndrome, anti-cardiolipin antibody and glomerular thrombosis.
    Stevens JM; Hunt JE; Seymour AE; Krilis SA; Pugsley DJ
    Clin Nephrol; 1994 Jan; 41(1):18-22. PubMed ID: 8137565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.